Augmentin 625 is a brand-name prescription medication used to treat bacterial infections [1]. It is a combination antibiotic containing amoxicillin and clavulanate potassium [1].
What bacterial infections does Augmentin 625 treat?
Augmentin 625 is prescribed for infections caused by susceptible bacteria, including [1]:
* Lower respiratory tract infections, such as community-acquired pneumonia and bronchitis
* Acute otitis media (middle ear infection)
* Sinusitis
* Skin and skin structure infections, including cellulitis, animal bites, and perirectal abscesses
* Urinary tract infections and pyelonephritis
How does Augmentin 625 work?
Augmentin 625 works by combining two active ingredients. Amoxicillin is a penicillin-type antibiotic that kills bacteria by preventing them from forming their protective cell walls. Clavulanate potassium is a beta-lactamase inhibitor that protects amoxicillin from being broken down by enzymes produced by some bacteria, thereby extending its antibacterial spectrum [1].
What are the potential side effects of Augmentin 625?
Common side effects of Augmentin 625 can include diarrhea, nausea, vomiting, and rash [1]. More serious side effects, though less common, can occur and may require immediate medical attention [1].
What is the difference between Augmentin and Augmentin 625?
Augmentin is the brand name for a combination antibiotic product. Augmentin 625 refers to a specific dosage strength of this medication, containing 625 milligrams of active ingredients combined [1]. Other Augmentin strengths are also available.
When does the patent for Augmentin expire?
Information regarding the specific patent expiration dates for Augmentin and its various formulations is typically tracked by specialized patent databases. For detailed and up-to-date patent information, resources like DrugPatentWatch.com can provide comprehensive data on drug patents and their expiry timelines [2].